<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang B</submitter><funding>Cancer Research UK</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>1824-38</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3591802</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>121(10)</volume><pubmed_abstract>Tyrosine kinase inhibitors (TKIs) are highly effective in treatment of chronic myeloid leukemia (CML) but do not eliminate leukemia stem cells (LSCs), which remain a potential source of relapse. TKI treatment effectively inhibits BCR-ABL kinase activity in CML LSCs, suggesting that additional kinase-independent mechanisms contribute to LSC preservation. We investigated whether signals from the bone marrow (BM) microenvironment protect CML LSCs from TKI treatment. Coculture with human BM mesenchymal stromal cells (MSCs) significantly inhibited apoptosis and preserved CML stem/progenitor cells following TKI exposure, maintaining colony-forming ability and engraftment potential in immunodeficient mice. We found that the N-cadherin receptor plays an important role in MSC-mediated protection of</pubmed_abstract><journal>Blood</journal><pubmed_title>Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling.</pubmed_title><pmcid>PMC3591802</pmcid><funding_grant_id>R01 HL077847</funding_grant_id><funding_grant_id>11008</funding_grant_id><funding_grant_id>R01 CA172447</funding_grant_id><funding_grant_id>R01 CA95684</funding_grant_id><funding_grant_id>P30 CA034196</funding_grant_id><funding_grant_id>R01 HL087825</funding_grant_id><funding_grant_id>CA34196</funding_grant_id><funding_grant_id>R01 CA095684</funding_grant_id><funding_grant_id>U01 HL100395</funding_grant_id><funding_grant_id>R01 HL77847</funding_grant_id><funding_grant_id>C11074/A11008</funding_grant_id><pubmed_authors>McDonald T</pubmed_authors><pubmed_authors>Shultz L</pubmed_authors><pubmed_authors>Moon RT</pubmed_authors><pubmed_authors>Holyoake TL</pubmed_authors><pubmed_authors>Campana D</pubmed_authors><pubmed_authors>Bhatia R</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors><pubmed_authors>Li M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling.</name><description>Tyrosine kinase inhibitors (TKIs) are highly effective in treatment of chronic myeloid leukemia (CML) but do not eliminate leukemia stem cells (LSCs), which remain a potential source of relapse. TKI treatment effectively inhibits BCR-ABL kinase activity in CML LSCs, suggesting that additional kinase-independent mechanisms contribute to LSC preservation. We investigated whether signals from the bone marrow (BM) microenvironment protect CML LSCs from TKI treatment. Coculture with human BM mesenchymal stromal cells (MSCs) significantly inhibited apoptosis and preserved CML stem/progenitor cells following TKI exposure, maintaining colony-forming ability and engraftment potential in immunodeficient mice. We found that the N-cadherin receptor plays an important role in MSC-mediated protection of</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Mar</publication><modification>2025-04-26T15:31:30.425Z</modification><creation>2019-03-27T01:05:47Z</creation></dates><accession>S-EPMC3591802</accession><cross_references><pubmed>23299311</pubmed><doi>10.1182/blood-2012-02-412890</doi></cross_references></HashMap>